12.06.2014
- Lonza has upgraded its Antibody Drug Conjugate (ADC) clinical manufacturing plant at Visp, Switzerland, with a new plant layout, which it said yields a larger, more flexible...
05.06.2014
- chemical producer Lonza, effective July 1. CEO of Swiss chemical manufacturer and distributor Kolb Ltd since 2012, Abend will have primary responsibility for corporate strategy and...
02.04.2014
- Annual results presented by global chemical companies for 2013 showed a diverse picture. This was scant surprise as many were still mired in a transformation process, while others...
11.03.2014
- Catalent Pharma Solutions announced two senior appointments to further strengthen its global biologics business. Andrew Sandford joins Catalent as Vice President Business...
11.02.2014
- Switzerland's narrow 50.3% approval of the nationalist party SVP's referendum to limit immigration on Feb. 9 could cause major staffing headaches for companies such as Novartis...
07.02.2014
- Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...
- Lonza announced today that Chugai Pharmaceutical Manufacturing (CPMC) has adopted Lonza's Quality Control Microbiology automation platform, MODA-EM for their environmental and...
28.10.2013
- Strategic Maneuvers - When Richard Ridinger took over as CEO of Basel, Switzerland-based Lonza in May 2012, the 115-year old life science and chemical company with sales of just...
